Abstract A093: Deciphering acquired resistance to KRASG12D inhibition in a mouse model of pancreatic ductal adenocarcinoma
Julien Dilly(Massachusetts Institute of Technology), Andrew J. Aguirre(Broad Institute), Shatavisha Dasgupta(Dana-Farber Cancer Institute), Connor J. Hennessey(Broad Institute), Srivatsan Raghavan(Broad Institute), Megan T. Hoffman(Massachusetts Institute of Technology), Seema Chugh(Broad Institute), Giselle A. Uribe(Broad Institute), Brendan Parent(Unknown), Brian M. Wolpin(Brigham and Women's Hospital), Laleh Abbassi(Broad Institute), Jonathan A. Nowak(Brigham and Women's Hospital), Peter Winter(Broad Institute), Felix P. Hambitzer(Dana-Farber Cancer Institute), Alexander C. Jordan(Broad Institute), Annan Yang(Dana-Farber Cancer Institute), Alex K. Shalek(Broad Institute), Qiang Li(Harvard University), Stephanie K. Dougan(Harvard University), Ziyue Li(Sichuan University), Kevin S. Kapner(Broad Institute)
Cited by 0
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.2k
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.4k
Draft genome sequence of chickpea (Cicer arietinum) provides a resource for trait improvement
|Nature Biotechnology|2013|1.3k